Use of Contrast Enhanced Spectral Mammography (CESM) for Women With Palpable Breast Abnormalities

Breast Abnormalities Clinical Trial

Official title:
Use of Contrast Enhanced Spectral Mammography (CESM) for Women With Palpable Breast Abnormalities

Status Active, not recruiting

Clinical Trial Summary

Contrast Enhanced Spectral Mammography (CESM) is an advanced form of mammography which is performed after injection of contrast or dye into a vein in the arm. This dye is the same dye that is used for CT scans. This type of mammogram includes a regular mammogram as well as additional pictures with the dye. This particular study is being done to determine if by adding the dye in the veins the investigators are better able to identify the cause of the lump than if they just did the regular mammogram alone.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02406274
Study type	Interventional
Source	Memorial Sloan Kettering Cancer Center
Contact
Status	Active, not recruiting
Phase	N/A
Start date	March 2015
Completion date	March 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01687790` - The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease	N/A
Recruiting	`NCT01106911` - Assessment of Digital Breast Tomosynthesis (DBT) in the Screening Environment	N/A
Terminated	`NCT00630318` - Testing New Method of Analyzing MR Images	Phase 1
Completed	`NCT00722059` - Detection and/or Evaluation of Dense Breast Abnormalities Using Tomosynthesis and Digital Mammography	Phase 0
Withdrawn	`NCT00722683` - Evaluate Breast Masses Using a New Method of Ultrasound Contrast to Detect Abnormal Blood Flow in Breasts	N/A